Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of rapid coronavirus test kits, rising focus on preventing the spread of coronavirus, and increasing government funding.
The coronavirus test kits market in Europe is segmented as below:
By End-user
- Government
- Non government
By Type
- Rapid test kit
- RT-PCR
- Others
By Geographical Landscape
- Europe
The report on the coronavirus test kits market in Europe covers the following areas:
- Coronavirus test kits market in Europe sizing
- Coronavirus test kits market in Europe forecast
- Coronavirus test kits market in Europe industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the coronavirus test kits market in Europe: 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio RAD Laboratories Inc., BioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc, Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, Perkin Elmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advent of SARS-CoV-2 mutation."
According to the report, one of the major drivers for this market is the rising adoption of rapid coronavirus test kits.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Biomedicine Science and Technology Co. Ltd.
- Abbott Laboratories
- altona Diagnostics GmbH
- BGI Genomics Co. Ltd.
- Bio Rad Laboratories Inc.
- BioMerieux SA
- BIOSYNEX SA
- Bruker Corp.
- Co Diagnostics Inc
- Danaher Corp.
- Edinburgh Genetics Ltd.
- F. Hoffmann La Roche Ltd.
- MultiplexDX
- Perkin Elmer Inc.
- QIAGEN N.V.
- Robert Bosch GmbH
- Sd Biosensor Inc.
- Seegene Inc.
- Thermo Fisher Scientific Inc.
- ZEKMED